Cargando…
Optimal Cerebral Perfusion Pressure Guided by Brain Oxygen Pressure Measurement
Background: Although increasing cerebral perfusion pressure (CPP) is commonly accepted to improve brain tissue oxygen pressure (PbtO(2)), it remains unclear whether recommended CPP targets (i. e., >60 mmHg) would result in adequate brain oxygenation in brain injured patients. The aim of this stud...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581172/ https://www.ncbi.nlm.nih.gov/pubmed/34777201 http://dx.doi.org/10.3389/fneur.2021.732830 |
_version_ | 1784596747074404352 |
---|---|
author | Kovacs, Matyas Peluso, Lorenzo Njimi, Hassane De Witte, Olivier Gouvêa Bogossian, Elisa Quispe Cornejo, Armin Creteur, Jacques Schuind, Sophie Taccone, Fabio Silvio |
author_facet | Kovacs, Matyas Peluso, Lorenzo Njimi, Hassane De Witte, Olivier Gouvêa Bogossian, Elisa Quispe Cornejo, Armin Creteur, Jacques Schuind, Sophie Taccone, Fabio Silvio |
author_sort | Kovacs, Matyas |
collection | PubMed |
description | Background: Although increasing cerebral perfusion pressure (CPP) is commonly accepted to improve brain tissue oxygen pressure (PbtO(2)), it remains unclear whether recommended CPP targets (i. e., >60 mmHg) would result in adequate brain oxygenation in brain injured patients. The aim of this study was to identify the target of CPP associated with normal brain oxygenation. Methods: Prospectively collected data including patients suffering from acute brain injury and monitored with PbtO(2), in whom daily CPP challenge using vasopressors was performed. Initial CPP target was >60 mmHg; norepinephrine infusion was modified to have an increase in CPP of at least 10 mmHg at two different steps above the baseline values. Whenever possible, the same CPP challenge was performed for the following days, for a maximum of 5 days. CPP “responders” were patients with a relative increase in PbtO(2) from baseline values > 20%. Results: A total of 53 patients were included. On the first day of assessment, CPP was progressively increased from 73 (70–76) to 83 (80–86), and 92 (90–96) mmHg, which resulted into a significant PbtO(2) increase [from 20 (17–23) mmHg to 22 (20–24) mmHg and 24 (22–26) mmHg, respectively; p < 0.001]. Median CPP value corresponding to PbtO(2) values > 20 mmHg was 79 (74–87) mmHg, with 2 (4%) patients who never achieved such target. Similar results of CPP targets were observed the following days. A total of 25 (47%) were PbtO(2) responders during the CPP challenge on day 1, in particular if low PbtO(2) was observed at baseline. Conclusions: PbtO(2) monitoring can be an effective way to individualize CPP values to avoid tissue hypoxia. Low PbtO(2) values at baseline can identify the responders to the CPP challenge. |
format | Online Article Text |
id | pubmed-8581172 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-85811722021-11-12 Optimal Cerebral Perfusion Pressure Guided by Brain Oxygen Pressure Measurement Kovacs, Matyas Peluso, Lorenzo Njimi, Hassane De Witte, Olivier Gouvêa Bogossian, Elisa Quispe Cornejo, Armin Creteur, Jacques Schuind, Sophie Taccone, Fabio Silvio Front Neurol Neurology Background: Although increasing cerebral perfusion pressure (CPP) is commonly accepted to improve brain tissue oxygen pressure (PbtO(2)), it remains unclear whether recommended CPP targets (i. e., >60 mmHg) would result in adequate brain oxygenation in brain injured patients. The aim of this study was to identify the target of CPP associated with normal brain oxygenation. Methods: Prospectively collected data including patients suffering from acute brain injury and monitored with PbtO(2), in whom daily CPP challenge using vasopressors was performed. Initial CPP target was >60 mmHg; norepinephrine infusion was modified to have an increase in CPP of at least 10 mmHg at two different steps above the baseline values. Whenever possible, the same CPP challenge was performed for the following days, for a maximum of 5 days. CPP “responders” were patients with a relative increase in PbtO(2) from baseline values > 20%. Results: A total of 53 patients were included. On the first day of assessment, CPP was progressively increased from 73 (70–76) to 83 (80–86), and 92 (90–96) mmHg, which resulted into a significant PbtO(2) increase [from 20 (17–23) mmHg to 22 (20–24) mmHg and 24 (22–26) mmHg, respectively; p < 0.001]. Median CPP value corresponding to PbtO(2) values > 20 mmHg was 79 (74–87) mmHg, with 2 (4%) patients who never achieved such target. Similar results of CPP targets were observed the following days. A total of 25 (47%) were PbtO(2) responders during the CPP challenge on day 1, in particular if low PbtO(2) was observed at baseline. Conclusions: PbtO(2) monitoring can be an effective way to individualize CPP values to avoid tissue hypoxia. Low PbtO(2) values at baseline can identify the responders to the CPP challenge. Frontiers Media S.A. 2021-10-28 /pmc/articles/PMC8581172/ /pubmed/34777201 http://dx.doi.org/10.3389/fneur.2021.732830 Text en Copyright © 2021 Kovacs, Peluso, Njimi, De Witte, Gouvêa Bogossian, Quispe Cornejo, Creteur, Schuind and Taccone. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neurology Kovacs, Matyas Peluso, Lorenzo Njimi, Hassane De Witte, Olivier Gouvêa Bogossian, Elisa Quispe Cornejo, Armin Creteur, Jacques Schuind, Sophie Taccone, Fabio Silvio Optimal Cerebral Perfusion Pressure Guided by Brain Oxygen Pressure Measurement |
title | Optimal Cerebral Perfusion Pressure Guided by Brain Oxygen Pressure Measurement |
title_full | Optimal Cerebral Perfusion Pressure Guided by Brain Oxygen Pressure Measurement |
title_fullStr | Optimal Cerebral Perfusion Pressure Guided by Brain Oxygen Pressure Measurement |
title_full_unstemmed | Optimal Cerebral Perfusion Pressure Guided by Brain Oxygen Pressure Measurement |
title_short | Optimal Cerebral Perfusion Pressure Guided by Brain Oxygen Pressure Measurement |
title_sort | optimal cerebral perfusion pressure guided by brain oxygen pressure measurement |
topic | Neurology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581172/ https://www.ncbi.nlm.nih.gov/pubmed/34777201 http://dx.doi.org/10.3389/fneur.2021.732830 |
work_keys_str_mv | AT kovacsmatyas optimalcerebralperfusionpressureguidedbybrainoxygenpressuremeasurement AT pelusolorenzo optimalcerebralperfusionpressureguidedbybrainoxygenpressuremeasurement AT njimihassane optimalcerebralperfusionpressureguidedbybrainoxygenpressuremeasurement AT dewitteolivier optimalcerebralperfusionpressureguidedbybrainoxygenpressuremeasurement AT gouveabogossianelisa optimalcerebralperfusionpressureguidedbybrainoxygenpressuremeasurement AT quispecornejoarmin optimalcerebralperfusionpressureguidedbybrainoxygenpressuremeasurement AT creteurjacques optimalcerebralperfusionpressureguidedbybrainoxygenpressuremeasurement AT schuindsophie optimalcerebralperfusionpressureguidedbybrainoxygenpressuremeasurement AT tacconefabiosilvio optimalcerebralperfusionpressureguidedbybrainoxygenpressuremeasurement |